Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:[email protected]

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CGRP Recombinant Antibody(Eptinezumab)

Product Information
Catalog Number YR1428
Product Name Anti-Human CGRP Recombinant Antibody(Eptinezumab)
Molecular Name Eptinezumab
Alias Anti-CGRP Recombinant Antibody, Research Grade Eptinezumab
CAS Number 1644539-04-7
Target CGRP[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications ELISA, IHC, IF, IP, FCM, Inhib
Buffer PBS, pH7.5
Background Eptinezumab, sold under the brand name Vyepti, is a medication for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion every three months. Eptinezumab-jjmr was approved for use in the United States in February 2020.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.